Table 4.
The association of MCM2 expression and survival in human BC patients.
| Dataset | Endpoint | Probe ID | N | Cox P-value | HR∗ |
|---|---|---|---|---|---|
| GSE12276 | Relapse Free Survival | 202107_s_at | 204 | 0.002833 | 1.42 |
| GSE9195 | Distant Metastasis Free Survival | 202107_s_at | 77 | 0.001732 | 3.99 |
| GSE9195 | Relapse Free Survival | 202107_s_at | 77 | 0.003532 | 3.04 |
| GSE11121 | Distant Metastasis Free Survival | 202107_s_at | 200 | 0.005174 | 2 |
| GSE1378 | Relapse Free Survival | 8241 | 60 | 0.006214 | 1.15 |
| GSE9893 | Overall Survival | 3845 | 155 | 0.000003 | 1.69 |
| GSE2034 | Distant Metastasis Free Survival | 202107_s_at | 286 | 0.029374 | 1.43 |
| GSE1456-GPL96 | Relapse Free Survival | 202107_s_at | 159 | 0.000724 | 2.08 |
| GSE1456-GPL96 | Disease Specific Survival | 202107_s_at | 159 | 0.004401 | 2.07 |
| GSE1456-GPL96 | Overall Survival | 202107_s_at | 159 | 0.02056 | 1.7 |
| E-TABM-158 | Disease Specific Survival | 202107_s_at | 117 | 0.013239 | 0.59 |
| GSE3494-GPL96 | Disease Specific Survival | 202107_s_at | 236 | 0.011551 | 1.81 |
| GSE4922-GPL96 | Disease Free Survival | 202107_s_at | 249 | 0.001042 | 1.82 |
| GSE7390 | Distant Metastasis Free Survival | 202107_s_at | 198 | 0.034357 | 1.33 |
| GSE7390 | Overall Survival | 202107_s_at | 198 | 0.0388 | 1.34 |
| GSE7390 | Relapse Free Survival | 202107_s_at | 198 | 0.033839 | 1.27 |
∗HR denotes the hazard ratio and N is the number of samples.